Republican presidential candidate Vivek Ramaswamy was previously the head of a biotech firm, Axovant Sciences. During the course of his campaign he has been criticized for using the firm to pump up the company’s stock surrounding an ineffective Alzheimer’s drug treatment before cashing out.